A small (n=60) RCT investigating citocoline's impact on attention deficits in women aged 40-60 found that citicoline at doses as low as 250 to 500 mg daily over 28 days nominally improved attentional deficits associated with CNS disorders. researchgate.net/publication/26…
ADVERSE EFFECTS
-GI irritation
-Possible neuropsych side effects (changes in mood, sleep patters) considering that citocoline does seem to affect neurotransmitters. It could be a positive or a negative depending on the individual.
DOSING
Considering the possibility of neuropsychiatric side effects, starting at a conservative dose of 250 mg once daily is warranted.
Recently I spoke w/ an MD who has treated ~40 #pwLC with an Rx omega-3 fatty acid similar to EPA known as icosapent ethyl (IPE, brand name Vascepa) w/ promising results. Turns out, it may help #pwME too.
Even patients who had suffered from Long COVID for over two years reportedly experienced improvements in sense of taste & smell, fatigue, sleep, joint pain, brain fog, and hair/nail growth. onlinescientificresearch.com/articles/propo…
This MD also treated ~140 acute COVID pts w/ IPE and reportedly none of them developed LC. The MITIGATE trial is currently investigating the ability of Vascepa (IPE) to reduce morbidity & mortality in a cohort of adults with URIs including SARS-CoV-2. ncbi.nlm.nih.gov/pmc/articles/P…
👏Good news for those with MCAS or histamine intolerance:
Serrapeptase (SP) inhibits release of histamine & thus it's plausible that SP may improve MCAS symptoms. Furthermore, co-administration of SP with nattokinase may improve tolerability & efficacy.
Some with MCAS were concerned that lumbrokinase production may involve fermentation. According to the VP of the company that manufactures Boluoke, their product does NOT involve fermentation.
Furthermore, Dr. Kwok confirms that lumbrokinase activity is reduced in acidic (gastric) pH; thus Boluoke includes acid resistant coating. This further supports my hypothesis that these proteolytic enzymes (NK, SP, LK) work better with enteric coatings.
I'm working on 4 LC/ME surveys. Which one interests you the most? See next few tweets for survey descriptions.
#1:
Covid & #LongCovid prevention: nasal sprays, probiotics, antivirals, & non-pharmacological measures that may ⬇️ infection or severity of/progression to LC.
Survey #2:
Anticoagulants/Anti-platelets (including aspirin) in #LongCovid & #MECFS - bleeding risk, what symptoms improved, how long did it take to see improvement, and do symptoms return with stopping? Compare those on triple therapy to those on monotherapy & aspirin, etc
Survey #3:
Investigates the top non-pharmacological measures from previous survey (vagal nerve stimulators, HBOT, craniosacral therapy, etc) in #LongCovid and #MECFS. Which symptoms did they help or hurt? May include sections for other post-viral illnesses if interest.
See 4 charts 1) Treatments with HIGHEST reported efficacy (50% to 78.5%) 2) Treatments middle of the pack 3) Treatments w/ reported efficacy under 30% 4) Worst tolerated treatments (winner: GET, which made vast majority WORSE)
🧵
Some treatments I have already surveyed. Of those, most matched up very closely with this most recent survey. I included whichever survey had the greater sample size.
One such example was VNS which didn't shine as much as I'd expected judging from other surveys & poll.
One BIG surprise:
When I tallied responses from the Viagra Poll, results were striking: of the 79 who took PDE5Is w/ LC or ME, 72% reported benefit & 30% reported that the drug helped "a lot"!
Could this be random tweeters trolling or is this accurate?
I've heard from several #pwLC & ME who reported their symptoms moderately to vastly improved following Viagra use.
Are these just wacky anecdotes or is there scientific basis for these positive effects?
Answer: the latter🧵
VIAGRA (sildenafil) & ME/CFS TRIAL
In 2008, Dr T Friedman hypothesized that Viagra would help ME/CFS patients by improving cerebral blood flow. He carried out a tiny placebo-controlled trial (n=12).
Change in Fatigue Impact Scale questionnaire suggested benefit with Viagra over placebo. However, only 5 on Viagra & 6 on placebo completed the trial & the study was never published.
Dosing:
Week 1: 25 mg TID*
Week 2: 50 mg TID
Weeks 3-6: 100 mg TID
*TID = 3 times daily
3/x